Prognosis prediction using significant pathological response following neoadjuvant immunotherapy in resectable non-small-cell lung tumors: a meta-analysis

作者
Fang Nie,Ying Wang,Wanting Shi,Liru Zhu,Jing Hao,Rancen Tao
出处
期刊:Frontiers in Surgery [Frontiers Media]
卷期号:11: 1500593-1500593 被引量:3
标识
DOI:10.3389/fsurg.2024.1500593
摘要

Background A meta-analysis study was done to figure out how to predict the prognosis of people with resectable non-small-cell lung cancer (NSCLC) who had a significant pathological response following neoadjuvant immunotherapy. Methods Up until August 2024, a comprehensive literature study was completed, and 2,386 connected studies were revised. The 35 selected studies included 3,118 resectable non-small-cell lung tumor participants at the beginning of the study. Using dichotomous techniques and a fixed or random model, the odds ratio (OR) and 95% confidence intervals (CIs) were used to assess the prediction using significant pathological response following neoadjuvant immunotherapy in resectable NSCLC. Results Individuals with resectable NSCLC had significantly higher major pathological response when comparing neoadjuvant chemo-immunotherapy to neoadjuvant chemotherapy (OR, 5.07; 95% CI, 4.09–6.27, p < 0.001), objective response rate to non-objective response rate (OR, 7.02; 95% CI, 4.28–11.50, p < 0.001), and programmed death-ligand 1 ≥1% to programmed death-ligand ≤1% (OR, 2.49; 95% CI, 1.44–4.30, p = 0.001). However, no significant difference was found in major pathological response between stage III and stage I-II (OR, 1.43; 95% CI, 0.88–2.33, p = 0.15), and squamous cell cancer and non-squamous cell cancer (OR, 1.35; 95% CI, 0.95–1.92, p = 0.09) in individuals with resectable NSCLCs. Conclusion Individuals with resectable NSCLCs had significantly higher major pathological response when comparing neoadjuvant chemo-immunotherapy to neoadjuvant chemotherapy, objective response rate to non-objective response rate, and programmed death-ligand 1≥1% to programmed death-ligand 1 ≤1%, however, no significant difference was found between stage III and stage I-II, and squamous cell cancer and non-squamous cell cancer. To validate this discovery, more research is required since most of the selected studies had a low sample size, and caution must be implemented when interacting with its values.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
桐桐的应助被jies采纳,获得10
刚刚
刚刚
小编一枚完成签到,获得积分10
刚刚
刚刚
雨雨雨雨完成签到,获得积分10
1秒前
zyf完成签到,获得积分10
1秒前
1秒前
2秒前
2秒前
2秒前
2秒前
2秒前
蹦沙卡拉卡完成签到,获得积分10
3秒前
3秒前
4秒前
2021完成签到 ,获得积分10
4秒前
jiang完成签到,获得积分10
4秒前
CipherSage的应助被Evelyn采纳,获得10
5秒前
自由可兰发布了新的文献求助10
5秒前
tt发布了新的文献求助10
5秒前
亚尔驳回了田様的应助
6秒前
xudaniel发布了新的文献求助10
6秒前
荷呵呵完成签到,获得积分10
6秒前
6秒前
TT123发布了新的文献求助10
6秒前
chengzinie发布了新的文献求助10
6秒前
6秒前
张晓发布了新的文献求助10
6秒前
西柚宝宝完成签到,获得积分10
6秒前
小贾完成签到,获得积分10
7秒前
7秒前
wy.he的应助被鲤鱼采纳,获得10
8秒前
非海星关注了科研通微信公众号
8秒前
8秒前
smh发布了新的文献求助10
9秒前
CipherSage的应助被heng采纳,获得10
9秒前
9秒前
顾鹏飞发布了新的文献求助10
9秒前
阿果发布了新的文献求助10
9秒前
jiang发布了新的文献求助10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8160268
求助须知:如何正确求助?哪些是违规求助? 9555328
关于积分的说明 21727231
捐赠科研通 7750062
什么是DOI,文献DOI怎么找? 3427353
关于科研通互助平台的介绍 2552391
邀请新用户注册赠送积分活动 2471707